{"id":45520,"date":"2022-06-27T12:02:10","date_gmt":"2022-06-27T10:02:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/"},"modified":"2022-06-27T12:02:10","modified_gmt":"2022-06-27T10:02:10","slug":"global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/","title":{"rendered":"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2986982\/global-molecular-diagnostics-partnering-terms-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=63whnj&amp;utm_campaign=1718831+-+Global+Molecular+Diagnostics+Partnering+Terms+and+Agreements+Report+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/21\/logo.jpg\"><\/a><\/p>\n<p>\n<strong>Key benefits<\/strong>\n<\/p>\n<ul>\n<li>\nIn-depth understanding of Molecular Diagnostics deal trends since 2015\n<\/li>\n<li>\nAccess to headline, upfront, milestone and royalty data\n<\/li>\n<li>\nDetailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies\n<\/li>\n<li>\nIdentify most active Molecular Diagnostics dealmakers since 2015\n<\/li>\n<li>\nInsight into terms included in a Molecular Diagnostics partnering agreement, with real world examples\n<\/li>\n<li>\nUnderstand the key deal terms companies have agreed in previous deals\n<\/li>\n<li>\nUndertake due diligence to assess suitability of your proposed deal terms for partner companies\n<\/li>\n<\/ul>\n<p>\nThis report provides details of the latest Molecular Diagnostics agreements announced in the life sciences since 2015.\n<\/p>\n<p>\nThe report presents financial deal term values for Molecular Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.\n<\/p>\n<p>\nThe middle section of the report explores the leading dealmakers in the Molecular Diagnostics partnering field; both the leading deal values and most active Molecular Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.\n<\/p>\n<p>\nOne of the key highlights of the report is that over 950 online deal records of actual Molecular Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.\n<\/p>\n<p>\nIn addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered &#8211; contract documents provide this insight where press releases and databases do not.\n<\/p>\n<p>\nThis report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Molecular Diagnostics technologies and products.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 &#8211; Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 &#8211; Trends in Molecular Diagnostics dealmaking<\/strong>\n<\/p>\n<p>\n2.1. Introduction\n<\/p>\n<p>\n2.2. Molecular Diagnostics partnering over the years\n<\/p>\n<p>\n2.3. Most active Molecular Diagnostics dealmakers\n<\/p>\n<p>\n2.4. Molecular Diagnostics partnering by deal type\n<\/p>\n<p>\n2.5. Molecular Diagnostics partnering by therapy area\n<\/p>\n<p>\n2.6. Deal terms for Molecular Diagnostics partnering\n<\/p>\n<p>\n<strong>Chapter 3 &#8211; Leading Molecular Diagnostics deals<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Top Molecular Diagnostics deals by value\n<\/p>\n<p>\n<strong>Chapter 4 &#8211; Most active Molecular Diagnostics dealmakers<\/strong>\n<\/p>\n<p>\n4.1. Introduction\n<\/p>\n<p>\n4.2. Most active Molecular Diagnostics dealmakers\n<\/p>\n<p>\n4.3. Most active Molecular Diagnostics partnering company profiles\n<\/p>\n<p>\n<strong>Chapter 5 &#8211; Molecular Diagnostics contracts dealmaking directory<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Molecular Diagnostics contracts dealmaking directory\n<\/p>\n<p>\n<strong>Chapter 6 &#8211; Molecular Diagnostics dealmaking by technology type<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\n2bPrecise\n<\/li>\n<li>\n2cureX\n<\/li>\n<li>\n3D BioMed\n<\/li>\n<li>\n3PrimeDx\n<\/li>\n<li>\n4D Path\n<\/li>\n<li>\n10X Genomics\n<\/li>\n<li>\n14M Genomics\n<\/li>\n<li>\n23andMe\n<\/li>\n<li>\n221b Foundation\n<\/li>\n<li>\nA*STAR Agency for Science\n<\/li>\n<li>\nTechnology and Research\n<\/li>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nAbbvie\n<\/li>\n<li>\nAbcam\n<\/li>\n<li>\nAbcodia\n<\/li>\n<li>\nAbramson Cancer Center\n<\/li>\n<li>\nAccelerate Diagnostics\n<\/li>\n<li>\nAccelerate Technologies\n<\/li>\n<li>\nAccess BIO\n<\/li>\n<li>\nAccuGenomics\n<\/li>\n<li>\nAccuRef Diagnostics\n<\/li>\n<li>\nAC Immune\n<\/li>\n<li>\nAcumen Pharmaceuticals\n<\/li>\n<li>\nAcupath Laboratories\n<\/li>\n<li>\nAdaptive Biotechnologies\n<\/li>\n<li>\nAdial Pharmaceuticals\n<\/li>\n<li>\nAditx Therapeutics\n<\/li>\n<li>\nADMA Biologics\n<\/li>\n<li>\nAdmera Health\n<\/li>\n<li>\nADS\n<\/li>\n<li>\nAdvanced Biological Laboratories\n<\/li>\n<li>\nAdvanced Cell Diagnostics\n<\/li>\n<li>\nAdvanced Cooling Therapy\n<\/li>\n<li>\nAdvanced Genomic Solutions\n<\/li>\n<li>\nAdvanced Medical German Company of Kuwait\n<\/li>\n<li>\nADx Healthcare\n<\/li>\n<li>\nAegea Biotechnologies\n<\/li>\n<li>\nAetna\n<\/li>\n<li>\nAffymetrix\n<\/li>\n<li>\nAge Labs\n<\/li>\n<li>\nAgena Bioscience\n<\/li>\n<li>\nAgendia\n<\/li>\n<li>\nAgilent Technologies\n<\/li>\n<li>\nAgios Pharmaceuticals\n<\/li>\n<li>\nAir Force Research Laboratory\n<\/li>\n<li>\nAkers Biosciences\n<\/li>\n<li>\nAko Med\n<\/li>\n<li>\nAkonni Biosystems\n<\/li>\n<li>\nAkoya Biosciences\n<\/li>\n<li>\nAlamar Biosciences\n<\/li>\n<li>\nAlbertsons Companies\n<\/li>\n<li>\nALBOT Technologies\n<\/li>\n<li>\nAldeyra Therapeutics\n<\/li>\n<li>\nAlibaba Health\n<\/li>\n<li>\nAllele Biotechnology and Pharmaceuticals\n<\/li>\n<li>\nAllelica\n<\/li>\n<li>\nAlliance Global FZ\n<\/li>\n<li>\nAlliance Global Group\n<\/li>\n<li>\nAlmac Diagnostics\n<\/li>\n<li>\nAlnylam Pharmaceuticals\n<\/li>\n<li>\nAlpha-Tec Systems\n<\/li>\n<li>\nAlphazyme\n<\/li>\n<li>\nAlverno Clinical Laboratories\n<\/li>\n<li>\nAlzheimer&#8217;s Drug Discovery Foundation\n<\/li>\n<li>\nAlzheon\n<\/li>\n<li>\nAmazon Web Services\n<\/li>\n<li>\nAmbry Genetics\n<\/li>\n<li>\nA Menarini Diagnostics\n<\/li>\n<li>\nAmerica&#8217;s Choice Provider Network\n<\/li>\n<li>\nAmgen\n<\/li>\n<li>\nAmoy Diagnostics\n<\/li>\n<li>\nAmplitech\n<\/li>\n<li>\nAnavasi Diagnostics\n<\/li>\n<li>\nAnchorDx\n<\/li>\n<li>\nAngle\n<\/li>\n<li>\nAngsana Molecular &amp; Diagnostics\n<\/li>\n<li>\nAnixa Biosciences\n<\/li>\n<li>\nAnnar Health Technologies\n<\/li>\n<li>\nAnpac Bio-Medical Science\n<\/li>\n<li>\nAnteoTech\n<\/li>\n<li>\nAnthem Bluecross\n<\/li>\n<li>\nAntisoma Therapeutics\n<\/li>\n<li>\nApplied BioCode\n<\/li>\n<li>\nAptorum Group\n<\/li>\n<li>\nArbor Biosciences\n<\/li>\n<li>\nArcherDX\n<\/li>\n<li>\nAres Genetics\n<\/li>\n<li>\nAres Life Sciences\n<\/li>\n<li>\nAriosa Diagnostics\n<\/li>\n<li>\nArisan Therapeutics\n<\/li>\n<li>\nArizona State University\n<\/li>\n<li>\nAroCell\n<\/li>\n<li>\nArrow Diagnostics\n<\/li>\n<li>\nAshion Analytics\n<\/li>\n<li>\nASPiRA Labs\n<\/li>\n<li>\nAspira Scientific\n<\/li>\n<li>\nAssistance Publique-Hopitaux de Paris\n<\/li>\n<li>\nAstellas Pharma\n<\/li>\n<li>\nAsterand Bioscience\n<\/li>\n<li>\nAsthma UK\n<\/li>\n<li>\nAstraZeneca\n<\/li>\n<li>\nAstute Medical\n<\/li>\n<li>\nAsuragen\n<\/li>\n<li>\nAsureQuality\n<\/li>\n<li>\nATGen Global\n<\/li>\n<li>\nAthletigen\n<\/li>\n<li>\nAtlas Antibodies\n<\/li>\n<li>\nAtlas Genetics\n<\/li>\n<li>\nAtlas Genomics\n<\/li>\n<li>\nAtomo Diagnostics\n<\/li>\n<li>\nAtrin Pharmaceuticals\n<\/li>\n<li>\nAtrys Health\n<\/li>\n<li>\nAutobio Diagnostics\n<\/li>\n<li>\nAutoGenomics\n<\/li>\n<li>\nAvacta\n<\/li>\n<li>\nAvalon GloboCare\n<\/li>\n<li>\nAvant Diagnostics\n<\/li>\n<li>\nAvera Health\n<\/li>\n<li>\nAvricore Health\n<\/li>\n<li>\nAxella Research\n<\/li>\n<li>\nAXIM Biotechnologies\n<\/li>\n<li>\nBabson Diagnostics\n<\/li>\n<li>\nBaebies\n<\/li>\n<li>\nBASE10 Genetics\n<\/li>\n<li>\nBay Area Lyme Foundation\n<\/li>\n<li>\nBayer\n<\/li>\n<li>\nBaylor Genetics\n<\/li>\n<li>\nBBI Solutions\n<\/li>\n<li>\nBC Neuroimmunology\n<\/li>\n<li>\nBC Platforms\n<\/li>\n<li>\nBD Biosciences\n<\/li>\n<li>\nBeckman Coulter\n<\/li>\n<li>\nBe Creative Lab\n<\/li>\n<li>\nBecton Dickinson\n<\/li>\n<li>\nBeijing Genomics Institute (BGI)\n<\/li>\n<li>\nBerg\n<\/li>\n<li>\nBeroni Group\n<\/li>\n<li>\nBerry Genomics\n<\/li>\n<li>\nBerry Oncology\n<\/li>\n<li>\nBertech Diagnostics\n<\/li>\n<li>\nBe The Match BioTherapies\n<\/li>\n<li>\nBHR Pharma\n<\/li>\n<li>\nBill and Melinda Gates Foundation\n<\/li>\n<li>\nBillionToOne\n<\/li>\n<li>\nBio-Me\n<\/li>\n<li>\nBio-Rad Laboratories\n<\/li>\n<li>\nBio-Techne\n<\/li>\n<li>\nbioAffinity Technologies\n<\/li>\n<li>\nBioAnalytical Systems\n<\/li>\n<li>\nBIOASTER\n<\/li>\n<li>\nBiocartis\n<\/li>\n<li>\nBiocept\n<\/li>\n<li>\nBioChain\n<\/li>\n<li>\nBioCheck\n<\/li>\n<li>\nBiodesix\n<\/li>\n<li>\nBiodirection\n<\/li>\n<li>\nBioDiscovery\n<\/li>\n<li>\nBiodist\n<\/li>\n<li>\nBiofidelity\n<\/li>\n<li>\nBioGemex\n<\/li>\n<li>\nBiognosys\n<\/li>\n<li>\nBioGX\n<\/li>\n<li>\nBiohealth Innovation\n<\/li>\n<li>\nBiohit Healthcare\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2986982\/global-molecular-diagnostics-partnering-terms-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=63whnj&amp;utm_campaign=1718831+-+Global+Molecular+Diagnostics+Partnering+Terms+and+Agreements+Report+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/v1z0qq<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#x3a;&#112;r&#x65;&#x73;&#x73;&#64;r&#x65;&#x73;&#x65;&#97;r&#x63;&#x68;&#x61;&#110;d&#x6d;&#x61;&#x72;&#107;e&#x74;&#x73;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">pre&#115;&#115;&#64;&#114;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;and&#109;&#97;&#114;&#107;&#101;&#x74;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Key benefits In-depth understanding of Molecular Diagnostics deal trends since 2015 Access to headline, upfront, milestone and royalty data Detailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies Identify most active Molecular &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45520","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Key benefits In-depth understanding of Molecular Diagnostics deal trends since 2015 Access to headline, upfront, milestone and royalty data Detailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies Identify most active Molecular ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-27T10:02:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-27T10:02:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/\"},\"wordCount\":821,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005346\\\/en\\\/1497446\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/\",\"name\":\"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005346\\\/en\\\/1497446\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-27T10:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005346\\\/en\\\/1497446\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220627005346\\\/en\\\/1497446\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Key benefits In-depth understanding of Molecular Diagnostics deal trends since 2015 Access to headline, upfront, milestone and royalty data Detailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies Identify most active Molecular ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-27T10:02:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-06-27T10:02:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/"},"wordCount":821,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/","name":"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/21\/logo.jpg","datePublished":"2022-06-27T10:02:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220627005346\/en\/1497446\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-molecular-diagnostics-partnering-terms-and-agreements-report-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45520"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45520\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}